David J. Moliterno

David J. Moliterno, MD, is a Professor in the Department of Internal Medicine at the University of Kentucky College of Medicine. He holds the Jack M. Gill Professorship and is affiliated with the Saha Cardiovascular Research Center and the CVRC as a Faculty Affiliate. His work is centered in cardiovascular medicine, particularly interventional cardiology, where he has made significant contributions through research and clinical leadership.

Dr. Moliterno’s research interests span interventional cardiology, antithrombotic therapy, acute coronary syndromes, and percutaneous coronary interventions (PCI). His work often focuses on optimizing dual antiplatelet therapy, managing stent thrombosis, and improving outcomes in high-risk cardiac patients. He has also contributed to innovations in medical illustration and knowledge dissemination in cardiology journals.

The trends in his recent publications reflect a strong emphasis on evidence-based cardiology, with major contributions to clinical trials and guideline development. His research integrates pharmacological, procedural, and systems-level approaches to improve cardiovascular care, particularly in complex patient populations such as those with prior bypass surgery or atrial fibrillation undergoing PCI.

He has received numerous professional honors, including:

• Fellow of the American College of Cardiology (FACC)
• Fellow of the American College of Physicians (FACP)
• Fellow of the American Heart Association (FAHA)
• Fellow of the European Society of Cardiology (FESC)
• Fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI)

Dr. Moliterno has authored or co-authored over 400 publications, including high-impact clinical trials in New England Journal of Medicine, Circulation, and JACC: Cardiovascular Interventions. While specific grant and advising details are not listed, his extensive collaborative work suggests significant involvement in large-scale research initiatives and mentorship within the cardiovascular research community. He is also associated with the Gill Heart and Vascular Institute, contributing to a multidisciplinary team focused on advancing cardiovascular science and patient care.